Total Payments
$1,918
2023 Payments
$834.11
Companies
17
Transactions
72
Medicare Patients
4,416
Medicare Billing
$516,146
Payment Breakdown by Category
Food & Beverage$1,756 (91.5%)
Consulting$162.10 (8.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,756 | 70 | 91.5% |
| Consulting Fee | $162.10 | 2 | 8.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $741.47 | 22 | $0 (2023) |
| Janssen Biotech, Inc. | $207.99 | 10 | $0 (2023) |
| INTERCEPT PHARMACEUTICALS, INC. | $191.42 | 6 | $0 (2023) |
| Ironwood Pharmaceuticals, Inc | $185.62 | 11 | $0 (2023) |
| COMSORT, Inc | $150.00 | 1 | $0 (2017) |
| CapsoVision, Inc. | $75.65 | 1 | $0 (2023) |
| Celgene Corporation | $74.31 | 4 | $0 (2023) |
| QOL Medical, LLC | $58.30 | 4 | $0 (2018) |
| Merck Sharp & Dohme Corporation | $45.37 | 3 | $0 (2020) |
| Daiichi Sankyo Inc. | $37.48 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $834.11 | 32 | ABBVIE INC. ($230.86) |
| 2022 | $49.21 | 3 | ABBVIE INC. ($22.02) |
| 2020 | $47.58 | 3 | IRONWOOD PHARMACEUTICALS, INC ($20.85) |
| 2019 | $183.41 | 10 | Janssen Biotech, Inc. ($66.66) |
| 2018 | $481.83 | 19 | AbbVie, Inc. ($328.30) |
| 2017 | $322.19 | 5 | COMSORT, Inc ($150.00) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/15/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 06/28/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $28.83 | General |
| Category: Immunology | ||||||
| 06/21/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.77 | General |
| Category: Neuroscience | ||||||
| 06/21/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Gastroenterology | ||||||
| 06/13/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: IMMUNOLOGY | ||||||
| 06/13/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: IMMUNOLOGY | ||||||
| 06/13/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.05 | General |
| Category: IMMUNOLOGY | ||||||
| 06/07/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: Immunology | ||||||
| 06/07/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $2.99 | General |
| Category: Immunology | ||||||
| 06/01/2023 | ABBVIE INC. | VIBERZI (Drug), LINZESS | Food and Beverage | In-kind items and services | $21.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 05/31/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $27.00 | General |
| Category: Immunology | ||||||
| 05/24/2023 | RedHill Biopharma Inc. | — | Food and Beverage | Cash or cash equivalent | $21.67 | General |
| 05/11/2023 | CapsoVision, Inc. | CapsoCam Plus (Device) | Food and Beverage | Cash or cash equivalent | $75.65 | General |
| Category: Gastroenterology | ||||||
| 05/09/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: Immunology | ||||||
| 05/09/2023 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $3.06 | General |
| Category: Immunology | ||||||
| 05/03/2023 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.51 | General |
| Category: Neuroscience | ||||||
| 05/02/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $23.14 | General |
| Category: IMMUNOLOGY | ||||||
| 05/02/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: IMMUNOLOGY | ||||||
| 04/26/2023 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/25/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 04/25/2023 | INTERCEPT PHARMACEUTICALS, INC. | OCALIVA (Drug) | Food and Beverage | In-kind items and services | $4.60 | General |
| Category: Hepatology / Gastroenterology | ||||||
| 04/04/2023 | Evoke Pharma, Inc. | GIMOTI (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: Gastroenterology | ||||||
| 03/29/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $27.68 | General |
| 03/23/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: IMMUNOLOGY | ||||||
| 03/22/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $3.88 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 813 | 877 | $205,176 | $78,201 |
| 2022 | 13 | 1,222 | 1,300 | $529,169 | $144,383 |
| 2021 | 13 | 1,258 | 1,379 | $574,493 | $176,250 |
| 2020 | 15 | 1,123 | 1,331 | $400,444 | $117,312 |
Total Patients
4,416
Total Services
4,887
Medicare Billing
$516,146
Procedure Codes
59
All Medicare Procedures & Services
59 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 124 | 141 | $35,325 | $16,841 | 47.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 135 | 161 | $20,125 | $13,746 | 68.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 47 | 47 | $8,366 | $7,166 | 85.7% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 45 | 45 | $35,550 | $6,967 | 19.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 58 | 58 | $11,750 | $6,200 | 52.8% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 22 | 22 | $19,514 | $5,593 | 28.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 28 | 28 | $11,060 | $4,441 | 40.2% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2023 | 18 | 18 | $11,934 | $4,003 | 33.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $14,586 | $3,911 | 26.8% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 34 | 35 | $18,305 | $3,669 | 20.0% |
| G0105 | Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 2023 | 12 | 12 | $7,956 | $2,659 | 33.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 80 | 93 | $1,860 | $781.20 | 42.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 26 | 27 | $891.00 | $601.56 | 67.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 39 | 40 | $1,200 | $547.56 | 45.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 50 | 52 | $1,300 | $395.72 | 30.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 34 | 36 | $4,464 | $372.60 | 8.3% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 19 | 19 | $570.00 | $157.51 | 27.6% |
| 82977 | Glutamyltransferase (liver enzyme) level | Office | 2023 | 20 | 21 | $420.00 | $148.26 | 35.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 222 | 261 | $80,593 | $28,602 | 35.5% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2022 | 61 | 61 | $90,000 | $19,778 | 22.0% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 45 | 45 | $65,500 | $19,376 | 29.6% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 52 | 52 | $77,000 | $17,970 | 23.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 62 | 62 | $90,500 | $17,955 | 19.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 86 | 86 | $39,826 | $13,130 | 33.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 106 | 126 | $30,850 | $10,432 | 33.8% |
About Dr. Jay Merker, MD
Dr. Jay Merker, MD is a Internal Medicine healthcare provider based in Great Neck, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1508933250.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Merker, MD has received a total of $1,918 in payments from pharmaceutical and medical device companies, with $834.11 received in 2023. These payments were reported across 72 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($1,756).
As a Medicare-enrolled provider, Merker has provided services to 4,416 Medicare beneficiaries, totaling 4,887 services with total Medicare billing of $516,146. Data is available for 4 years (2020–2023), covering 59 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Gastroenterology
- Location Great Neck, NY
- Active Since 11/29/2006
- Last Updated 05/03/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1508933250
Products in Payments
- Humira (Biological) $363.59
- OCALIVA (Drug) $191.42
- REMICADE (Biological) $141.33
- RINVOQ (Biological) $125.00
- SKYRIZI (Biological) $106.73
- LINZESS (Drug) $93.42
- Linzess (Drug) $92.20
- CapsoCam Plus (Device) $75.65
- ZEPOSIA (Drug) $74.31
- STELARA (Biological) $66.66
- Sucraid (Drug) $58.30
- DIFICID (Drug) $45.37
- INJECTAFER (Drug) $37.48
- IBSRELA (Drug) $21.61
- VIBERZI (Drug) $21.15
- REBYOTA (Biological) $20.66
- XIFAXAN (Drug) $18.15
- GIMOTI (Drug) $15.94
- KRISTALOSE (Drug) $13.61
- Kristalose (Drug) $11.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Great Neck
Dr. Jamie Hirsch, Md, MD
Internal Medicine — Payments: $69,165
Internal Medicine $69,165
Joanne Lee, M.d, M.D
Internal Medicine — Payments: $36,469
Internal Medicine $36,469
Bernard Rosof
Internal Medicine — Payments: $26,679
Internal Medicine $26,679
Dr. Shahram Shamekh, Md, MD
Internal Medicine — Payments: $18,187
Internal Medicine $18,187
Sanford Ratner, M.d, M.D
Internal Medicine — Payments: $16,933
Internal Medicine $16,933
David Edelson, Md, MD
Internal Medicine — Payments: $15,163
Internal Medicine $15,163